Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
mRNA | NOP56 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | NDUFAF4 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | SRSF11 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | IGFBP4 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
mRNA | PCYOX1 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-07 |
mRNA | SNRPD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | SNRPF | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | TRA2B | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |